Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: A double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial

European Journal of Neurology

Volumn 12, Issue 10, 2005, Pages 759-767

  Cerbo, R ^a   Centonze, V ^b   Grazioli, Irene ^c   Tavolato, B ^d   Trenti, T ^e   Uslenghi, C ^c   Sternieri, E ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Solvay Pharma SpA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Caffeine; Indomethacin; Nimesulide; Prochlorperazine; Tension type headache

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIEMETIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CAFFEINE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INDOMETACIN; INDOMETACIN PLUS PROCHLORPERAZINE PLUS CAFFEINE; KAINIC ACID; METHYLXANTHINE DERIVATIVE; MORPHINE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; SUMATRIPTAN; UNCLASSIFIED DRUG; UREA;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFMETRE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; EPISODIC TENSION HEADACHE; FEMALE; GASTRITIS; HUMAN; KAPLAN MEIER METHOD; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MULTICENTER STUDY; OUTCOMES RESEARCH; PAIN ASSESSMENT; PARAMETER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; RHINOCONJUNCTIVITIS; SCORING SYSTEM; STATISTICAL ANALYSIS; STOMACH PAIN; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CAFFEINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROCHLORPERAZINE; RETROSPECTIVE STUDIES; SULFONAMIDES; TENSION-TYPE HEADACHE; TIME FACTORS; TREATMENT OUTCOME;

EID: 27144512458     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2005.01056.x     Document Type: Article

References (42)

1. Anonymous (2002a). SCRIP World Pharmaceuticals News. PJB Publications, Ltd., London. No 2781, September 13. 24 p.
2. Anonymous (2002b). SCRIP World Pharmaceuticals News. PJB Publications, Ltd., London. No 2744, May 8/10. 24 p.
3. Antonaci F, Pareja JA, Caminero AB, Sjaastad O (1998). Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: the 'indotest'. Headache 38:122-128.
4. Coppola M, Yealy DM, Leibold RA (1995). Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 26:541-546.
5. Davis R, Brogden RN (1994). Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 48:431-454.
6. Diamond ML (2002). The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine. Neurology 58(9 Suppl. 6):3-9.
7. Diamond S, Balm TK, Freitag FG (2000). Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 68:312-319.
8. Di Monda V, Nicolodi M, Aloisio A et al. (2003). Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in the acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache 43:835-844.
9. Dodick DW, Jones JM, Capobianco DJ (2000). Hypnic headache: another indomethacin-responsive headache syndrome? Headache 40:830-835.
10. Donnet A, Lucas C, Massardier E, Boulliat J (2003). Hemicrania with response to indomethacin and prevalent autonomic symptoms: four cases. Cephalalgia 23:157-160.
11. Ferrari A, Pasciullo G, Savino G et al. (2004). Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study. Cephalalgia 24:356-362.
12. 1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633-658.
13. Galeotti N, Ghelardini C, Grazioli I, Uslenghi C (2002). Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine. Pharmacol Res 46:245-250.
14. Ghelardini C, Galeotti N, Bartolini A (1997). Caffeine induces central cholinergic analgesia. Naunyn Schmiedebergs Arch Pharmacol 356:590-595.
15. Ghelardini C, Galeotti N, Uslenghi C, Grazioli I, Bartolini A (2004). Prochlorperazine induces central antinociception mediated by the muscarinic system. Pharmacol Res 50:351-358.
16. Ghelardini C, Galeotti N, Grazioli I, Uslenghi C (2004). Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. J Pain 5:413-419.
17. Giacovazzo M, Gallo MF, Guidi V, Rico R, Scaricabarozzi I (1993). Nimesulide in the treatment of menstrual migraine. Drugs 46 (Suppl. 1):140-141.
18. Hannerz J (2000). Chronic bilateral headache responding to indomethacin. Headache 40:840-843.
19. Headache Classification Committee of the International Headache Society (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl. 7):1-96.
20. Headache Classification Subcommittee of the International Headache Society (2004). The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24 (Suppl. 1):9-160.
21. Hu XH, Tang HW, Li QS, Huang XF (1994). Central mechanism of indomethacin analgesia. Eur J Pharmacol 263:53-57.
22. Intercontinental Marketing Services (2004). The Pharmaceutical Market. IMS - Intercontinental Marketing Services, Italy.
23. International Headache Society Committee on Clinical Trials (1995). Guidelines for trials of drug treatments in tension-type headache. First edition. Cephalalgia 15:165-179.
24. Ivanez V, Soler R, Barreiro P (1998). Hypnic headache syndrome: a case with good response to indomethacin. Cephalalgia 18:225-226.
25. Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK Jr (1994). Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med 24:237-241.
26. Jones J, Sklar D, Dougherty J, White W (1989). Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 261:1174-1176.
27. Kaniecki RG (2002). Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 58 (9 Suppl. 6):S15-20.
28. Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A (1984). Caffeine as an analgesic adjuvant. JAMA 251:1711-1718.
29. Lu SR, Fuh JL, Juang KD, Wang SJ (2000). Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. Headache 40:724-729.
30. Martinez-Martin P, Raffaelli E Jr, Titus F et al. (2001). Efficacy and safety of metamizol versus acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo-and active-controlled, multicentre study. Cephalalgia 21:604-610.
31. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT (1994). Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 56:576-586.
32. Pareja JA, Caminero A., Franco E, Casado JL, Pascual J, Sanchez del Rio M (2001). Dose, efficacy and tolerability of long-term treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 21:906-910.
33. Prior MJ, Cooper KM, May LG, Bowen DL (2002). Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia 22:740-748.
34. Rabello GD, Forte LV, Galvao AC (2000). Clinical evaluation of the efficacy of the paracetamol and caffeine combination in the treatment of tension headache. Arq Neuropsiquiatr 58:90-98.
35. Rasmussen BK, Jensen R, Schroll M, Olesen J (1992). Interrelations between migraine and tension-type headache in the general population. Arch Neurol 49:914-918.
36. Rozen TD (2000). LASH: a syndrome of long-lasting autonomic symptoms with hemicrania (a new indomethacin-responsive headache). Headache 40:483-486.
37. Sharma S, Prasad A, Nehru R et al. (2002). Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine. Headache 42:896-902.
38. Sicuteri F, Michelacci S, Anselmi B (1965). Termination of migraine headache by a new anti-inflammatory vasoconstrictor agent. Clin Pharmacol Ther 6:336-344.
39. Sicuteri F, Nicolodi M (1997). The holistic hypothesis of migraine. Ann Ital Med Int 12 (Suppl. 1):3S-32S.
40. Solomon S, Newman LC (1999). Chronic daily bilateral headache responsive to indomethacin. Headache 39:754-757.
41. Steiner TJ, Lange R, Voelker M (2003). Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 23:59-66.
42. Ward N, Whitney C, Avery D, Dunner D (1991). The analgesic effects of caffeine in headache. Pain 44:151-155.